Off-label Prescribing: When the Risk Becomes the Manufacturer's Problem

A patient receives a medication for a condition the drug was never approved to treat. The prescription works as the doctor intended, or it does not. Weeks later, the patient suffers a stroke, a heart attack, a severe allergic reaction, or a debilitating side effect that changes the family's life. The question that follows is often the same: who is responsible when the drug was used "off-label"?

The answer is rarely simple, but it is not hopeless. Off-label prescribing is legal and common. The law does not automatically treat it as negligence. What matters is whether someone — a manufacturer, a prescriber, or both — breached a duty owed to the patient. Understanding where that line falls helps injured people and their families decide what to do next.

Why Off-Label Prescribing Is Legal — and When It Crosses the Line

The U.S. Food and Drug Administration approves drugs for specific uses, doses, and patient populations. Once a drug is on the market, however, licensed physicians may prescribe it for other uses based on their clinical judgment. This is off-label prescribing, and it is entirely lawful.

Courts and medical boards have long recognized that the practice of medicine is not limited to FDA-approved labels. A physician may prescribe off-label when the decision is supported by medical evidence, specialty guidelines, or a reasonable assessment of the patient's needs. In many cases, off-label use is the standard of care.

The legal trouble begins elsewhere. A manufacturer may not promote a drug for unapproved uses. When a company markets a medication for off-label purposes, minimizes known risks, or fails to update its warnings as new safety data emerges, it can be held liable for the injuries that follow.

This is where product liability law intersects with medical negligence. A manufacturer has a duty to warn physicians and patients about risks it knew or should have known about. A prescriber has a duty to obtain informed consent and to prescribe within accepted standards. When either duty is breached and a patient is harmed, a civil claim may exist.

Off-label use itself is not the injury. The injury comes from a failure to warn, a failure to disclose, or a failure to follow the standard of care.

Consider a common scenario. A drug approved for one condition is aggressively marketed by sales representatives for a different, unapproved use. The company's internal emails show it knew about a serious cardiac risk but chose not to update the label. A doctor, relying on that marketing, prescribes the drug off-label. The patient suffers a heart attack. In that case, the manufacturer's conduct — not the off-label prescription alone — may be the foundation of a claim.

Informed consent is another critical piece. Patients have the right to know the material risks of a proposed treatment, including risks associated with off-label use. If a physician fails to disclose those risks and the patient would have declined the treatment had they been informed, a negligence claim may arise.

Families should also understand that the standard of care is not a single national rule. It is shaped by what a reasonably prudent physician in similar circumstances would do. Expert testimony often determines whether the prescriber met that standard or fell below it.

What Injured Patients and Families Should Do After a Suspected Off-Label Injury

The first priority is medical care. Documenting symptoms, diagnoses, and treatments creates a record that will matter later. Families should keep every prescription bottle, pharmacy receipt, and discharge summary.

Preserving evidence is urgent. Drug manufacturers and healthcare providers have retention policies, and some records are destroyed on routine schedules. A patient or family member should send written requests to preserve all records, including the prescribing physician's notes, the pharmacy's dispensing records, and any communications with the manufacturer's sales representatives.

It also helps to write down a timeline while memories are fresh. When was the drug first prescribed? What was the patient told? Did the patient report side effects? Was the dose changed? These details can shape the direction of an investigation.

An attorney experienced in pharmaceutical injury cases can obtain internal company documents, marketing materials, and adverse-event reports that are not publicly available. These records often reveal whether a manufacturer knew about a risk and failed to act.

Deadlines matter. Every state has a statute of limitations for personal injury and product liability claims. The clock generally starts when the injury is discovered or should reasonably have been discovered, but the rules vary. Some states also have statutes of repose that set an absolute deadline regardless of discovery. Missing these deadlines can bar a claim entirely.

Compensation in these cases may include medical expenses, lost wages, pain and suffering, and in some circumstances punitive damages when a manufacturer's conduct was especially reckless. Most pharmaceutical injury attorneys work on a contingency fee, meaning the client pays nothing unless the case resolves in their favor.

Families should ask potential attorneys about their experience with off-label marketing litigation, their access to experts, and how they will handle the cost of investigation. A editorial review is standard and carries no obligation.

• Preserve all records immediately. Send written preservation letters to the prescribing physician, the pharmacy, and the manufacturer.
• Document the timeline. Note when the drug was prescribed, what the patient was told, and when symptoms began.
• Consult an attorney before speaking with manufacturer representatives. Statements made to company personnel can be used against a claim later.
• Act before the statute of limitations expires. Waiting can permanently eliminate the right to recover.

Frequently Asked Questions

Q: Is off-label prescribing always illegal or negligent?
No. Off-label prescribing is legal and often appropriate. A claim arises only when a manufacturer promotes the unapproved use, fails to warn about known risks, or a physician breaches the standard of care or fails to obtain informed consent.

Q: How long does a patient have to file a claim?
Every state sets its own statute of limitations for personal injury and product liability claims. The deadline usually begins when the injury is discovered or should have been discovered, but some states impose absolute cutoff dates, so prompt action is essential.

Q: What evidence matters most in an off-label injury case?
Internal manufacturer communications, marketing and sales materials, adverse-event reports, the drug's label and label changes, the prescribing physician's records, and the patient's medical history all matter. Preservation letters help ensure these records are not lost.

Q: What does it cost to pursue a claim?
Most pharmaceutical injury attorneys handle cases on a contingency fee, meaning there is no upfront cost and the attorney is paid only if the case resolves successfully. A free case review can clarify whether a claim exists.

If you or a family member is dealing with an injury you suspect was caused by negligence, request a free, confidential case review through this site. A quick review can tell you where you stand and what your options are.